Navigation Links
Kinerase® Introduces "Change Your Skin, Change Your Life" Charity Campaign
Date:5/16/2011

BRIDGEWATER, N.J., May 16, 2011 /PRNewswire/ -- Valeant Pharmaceuticals North America LLC is pleased to announce the launch of the "Change Your Skin, Change Your Life," campaign, in which their sub-brand Kinerase will make three charitable donations in 2011.

Each donation, which will be made in June, September and December, will be decided upon by consumer suggestions on the Kinerase Facebook page (www.facebook.com/kinerase). Participants will submit their favorite charities and then vote on the ones they like. The charities will then be narrowed down to the three most popular, at which time fans will have one week to vote again. The charity with the most votes will be the beneficiary of Kinerase's donation.

Each donation will consist of 20% of the proceeds from sales of a selected product for a one month period at Ulta. The first product will be the Kinerase Lotion in Q2 (June), the second will be the Kinerase Intensive Eye Cream in Q3 (September) and the last will be the Kinerase Cream in Q4 (December).

The voting process will begin Monday, May 16th, when voters will submit the name of their favorite charity and on May 31st the winning charity will be announced. Immediately following voters are encouraged to visit their local ULTA and purchase Kinerase where a percentage of the proceeds will go to the charity.

"'Change Your Skin, Change Your Life' is about bringing the consumer closer to the brand," said Jennifer Smoot, Director of Marketing for Kinerase. "By engaging consumers directly via Facebook and allowing them to make influential decisions for the brand, we hope to increase brand awareness and make a difference at the same time."

AVAILABILITY

Kinerase® is available at Kinerase.com, Ulta, Ulta.com, Nordstrom and Nordstrom.com. To purchase Kinerase by phone, call 1-800-826-9755.

ABOUT VALEANT PHARMACEUTICALS:

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Valeant has over 20 years of experience in dermatological science.  More information about Valeant can be found at www.valeant.com.


'/>"/>
SOURCE Valeant Pharmaceuticals North America LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amnis Introduces New FlowSight Imaging Flow Cytometer
2. Alma Lasers Introduces the iPixel Fractional Ablative Technology
3. Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix
4. BrightLife Direct Introduces 3 New Lymphedema Product Lines
5. Zimmer Introduces New Generation of the Wallis® Dynamic Stabilization System
6. Linet Introduces The Innovative Multicare Hospital Bed for High Acuity Patient Environments
7. Stereotaxis Introduces New Electrophysiology Platform: Epoch™
8. LATEST Medical Introduces New Kind of Patient Information Web Site - LATESTBreastCancer.com
9. KEMET Introduces Tantalum Stacked Capacitors
10. Osseon™ Therapeutics Introduces Osseoflex® BT Steerable Bone Tamp
11. Covaris Introduces Bench-top, AFA-based Process Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/12/2017)... , June 12, 2017 Kineta, Inc., a biotechnology ... Kineta Vice President of R&D and Head of ... Pandemic Preparedness for the Northwest and Beyond meeting ... on June 14, 2017 from 8:30-10:30 AM PDT at the ... Dr. Bedard will be joined by other ...
(Date:6/9/2017)... and INDIANAPOLIS , June 9, ... living with diabetes. In a further effort to help ... affected by this condition, the International Diabetes Federation (IDF) ... ) have come together for the second phase of ... Systems programme (BRIDGES 2), reaffirming their commitment to helping ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
Breaking Medicine Technology:
(Date:6/22/2017)... ... 2017 , ... Vighter, a premier provider of Unconventional Medical ... PSC.1-2012. The company’s work in countries throughout Southwest Asia, South America, and the ... degraded. The PSC.1 standard was created to protect fundamental freedoms and human rights ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... services, announced today that Claritas Capital, a Nashville-based private equity firm, has invested ... our expansion plans for some time, and Claritas Capital offers the smart money, ...
(Date:6/20/2017)... ... June 20, 2017 , ... After months of negotiations, FaceCradle USA is proud to ... on Wednesday, June 21. , “Introducing our product on QVC is something we all worked ... our travel pillow to more than 90 million homes in the United States,” said FaceCradle ...
(Date:6/20/2017)... , ... June 20, 2017 , ... Fresenius Vascular Care, ... minimally invasive techniques to treat and manage a wide range of vascular conditions, has ... initiative. With more than 65 centers represented by more than 40 local brands, a ...
(Date:6/20/2017)... ... June 20, 2017 , ... HOUSTON – Brazos Towers at Bayou Manor ... of new options for today’s modern senior. Brazos Towers at Bayou Manor has more ... love while offering them the services to support that lifestyle both now and in ...
Breaking Medicine News(10 mins):